CTOs on the Move

Bionix Development

www.bionix.com

 
Bionix Medical Technologies has provided medical professionals with innovative medical devices since 1984. Bionix is proud to offer cerumen removal, wound care, feeding tube care, infant feeding, bolus control and nasal visualization products.
  • Number of Employees: 25-100
  • Annual Revenue: $10-50 Million
  • www.bionix.com
  • 5154 Enterprise Blvd
    Toledo, OH USA 43612
  • Phone: 800.551.7096

Executives

Name Title Contact Details

Similar Companies

NeoVista

NeoVista Inc. is a Fremont, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

ManthaMed

ManthaMed is a Mississauga, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Walters Healthcare Resources

Walters Healthcare Resources is a Palmer, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Bodycad

Bodycad helps healthcare professionals and patients achieve their common pursuit of perfection by actualizing personalized orthopedic restorations. Bodycad enables orthopedic surgeons to create a personalized restoration based on the anatomical specifications of their patient using the company`s proprietary Personalized Restoration Software. Surgeons can quickly and efficiently step through the Bodycad PREP (Personalized Restoration Evaluation Process) to scan their patients and create a specific design plan, approve the design, and perform the restoration. The company is committed to providing high-touch education, training and service, including access to Bodycad PREP Techs to help assure surgical success. Bodycad is transforming the current standard of orthopedic implants to help surgeons and patients achieve their mutual goal of a perfect personalized restoration.

Cordis

With more than a 60-year history of pioneering products to treat millions of patients, Cordis is a worldwide leader in the development and manufacturing of interventional cardiovascular technology. Cordis established a legacy of high-quality and minimally-invasive cardiovascular products; and has built a robust global footprint with operations in more than 60 countries around the world. As from August 2, 2021, Cordis is a standalone company, and is committed to investing $300 million to accelerate innovation in its broad product portfolio. Building on our storied brand, we are unleashing our potential to be a $10 billion leader bringing new technology to the market through bold action at speed.